Skip to main content
Loading…

Seòmar agus comataidhean

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search.  There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Criathragan Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 4 May 2021
  6. Current session: 13 May 2021 to 2 April 2026
Answer status
Question type

Displaying 48968 questions Show Answers

Order by |

Question reference: S6W-41745

  • Asked by: Liam Kerr, MSP for North East Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 06 November 2025
  • Current Status: Answered by Angela Constance on 18 November 2025

To ask the Scottish Government, in light of a 42% increase in referrals to Prevent in Scotland in the last year, what it is doing to tackle each of the recorded types of concern.

Question reference: S6W-41676

  • Asked by: Ash Regan, MSP for Edinburgh Eastern, Independent
  • Date lodged: Thursday, 06 November 2025
  • Current Status: Answered by Jenni Minto on 18 November 2025

To ask the Scottish Government whether it will provide an update on the work undertaken by the NHS Research Scotland Mental Health Network, sponsored by Compass Pathways, in relation to a trial that commenced in Edinburgh in 2024 as part of a Scottish phase of a worldwide clinical study into the safety and effectiveness of an investigational psilocybin treatment for patients with treatment-resistant depression.

Question reference: S6W-41677

  • Asked by: Ash Regan, MSP for Edinburgh Eastern, Independent
  • Date lodged: Thursday, 06 November 2025
  • Current Status: Answered by Maree Todd on 18 November 2025

To ask the Scottish Government whether it has consulted the National Drugs Mission Clinical Advisory Group regarding its position on the potential impact of the reclassification of psilocybin on the treatment of people in Scotland with substance abuse disorders.

Question reference: S6W-41710

  • Asked by: Douglas Lumsden, MSP for North East Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 06 November 2025
  • Current Status: Answered by Gillian Martin on 18 November 2025

To ask the Scottish Government whether it has approved the proposed “Heroes of Net Zero” campaign, and, if so, what the (a) objectives, (b) target audiences and (c) delivery timeline and key milestones are, and whether it will provide details of any forecast or actual costs for each financial year of the campaign, including any costs to date.

Question reference: S6W-41642

  • Asked by: Murdo Fraser, MSP for Mid Scotland and Fife, Scottish Conservative and Unionist Party
  • Date lodged: Monday, 03 November 2025
  • Current Status: Answered by Ivan McKee on 18 November 2025

To ask the Scottish Government how much money in each local authority area has been raised from sporting rates in each of the last five years, also broken down by how much was then passed to the Scottish Land Fund to help fund community purchases of land.

Question reference: S6W-41671

  • Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
  • Date lodged: Tuesday, 04 November 2025
  • Current Status: Answered by Neil Gray on 18 November 2025

To ask the Scottish Government, further to the answer to question S6W-29116 by Neil Gray on 6 September 2024, whether it will provide an update on what total cost has been incurred to date in relation to the planned National Treatment Centre in NHS (a) Ayrshire and Arran, (b) Grampian, (c) Lanarkshire, (d) Lothian and (e) Tayside.

Question reference: S6W-41669

  • Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 04 November 2025
  • Current Status: Answered by Natalie Don-Innes on 18 November 2025

To ask the Scottish Government, in light of the forthcoming expansion of the Armed Forces Covenant, which might include an expansion into early years and childcare, what discussions it has had with the Care Inspectorate to ensure that it considers the covenant in its inspections.

Question reference: S6W-41664

  • Asked by: Tim Eagle, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 04 November 2025
  • Current Status: Answered by Gillian Martin on 18 November 2025

To ask the Scottish Government, further to the answer to question S6W-41468 by Gillian Martin on 27 October 2025, for what reason communities will need to apply through the Community Asset Transfer Scheme (CATS), and not be paying a rent to Forestry and Land Scotland, similar to how a commercial developer would.

Question reference: S6W-41742

  • Asked by: Tim Eagle, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Submitting member has a registered interest.

  • Date lodged: Friday, 07 November 2025
  • Current Status: Answered by Jim Fairlie on 18 November 2025

To ask the Scottish Government for what reason many Future Farming Investment Scheme applications from island communities were reportedly rejected. 

Question reference: S6W-41674

  • Asked by: Ash Regan, MSP for Edinburgh Eastern, Independent
  • Date lodged: Thursday, 06 November 2025
  • Current Status: Answered by Jenni Minto on 18 November 2025

To ask the Scottish Government what assessment it has made of any lessons learned, that may be relevant to Scotland, regarding the Australian Government's approval in 2023 for psychiatrists to prescribe MDMA for post-traumatic stress disorder, and psilocybin for treatment-resistant depression.